Peter Moussa, MD, MSc
Peter Moussa, MD, MSc
Specialty: Hematology/Oncology
Program: MMG Ambulatory HemOnc
Language(s): English
-
Overview
Cancer Focus:
Bladder Cancer, Colon Cancer, Colorectal Cancer, Kidney (Renal Cell) Cancer, Lung Cancer, Pancreatic Cancer, Prostate Cancer, Rectal CancerDr. Moussa received his MD degree at St George’s University, Grenada, West Indies. He completed an Internal Medicine Residency at Albert Einstein Medical Center, Philadelphia, Pennsylvania, followed by a Hematology/Oncology Fellowship at the University of California San Diego School of Medicine. Dr. Moussa joins Moffitt from Lee Health, Fort Myers, Florida, where he was a hematology/oncology physician.
Dr. Moussa specializes in the treatment of gastrointestinal malignancies, specifically colorectal and pancreatic malignancies, as well as lung, and genitourinary malignancies. His research interests focus on precision oncology and discovery of biomarkers to enhance understanding of tumor biology and prediction of treatment efficacy.
-
Publications
- Moussa P, Kurzrock R, Nishizaki D, Miyashita H, Lee S, Nikanjam M, Jensen TJ, Conroy JM, DePietro P, Sicklick JK, Kato S. GITR and GITR-L RNA Expression Levels Correlate with Better Survival and Response to Immunotherapy. Mol Cancer Ther. 2026 May. Pubmedid: 42083087.
- Moussa P, Kurzrock R, Nishizaki D, Miyashita H, Lee S, Nikanjam M, Jensen TJ, Conroy JM, DePietro P, Sicklick JK, Kato S. GITR and GITR-L RNA Expression Levels Correlate with Better Survival and Response to Immunotherapy. Mol Cancer Ther. 2026 May.OF1-OF11. Pubmedid: 42179191.
- Sedhom R, Beshai R, Moussa P, Megaly M, Mohsen A, Abramov D, Stoletniy L, Elgendy IY. Outcomes With Malignancy-Associated High-Risk Pulmonary Embolism: A Nationwide Analysis. Mayo Clin Proc. 2024 Jan.99(1):81-89. Pubmedid: 37632484.
- Moussa P, Kurzrock R, Nishizaki D, Miyashita H, Lee S, Nikanjam M, Pabla S, Nesline MK, Ko H, Conroy JM, DePietro P, Sicklick JK, Kato S. Transcriptomic analysis of GITR and GITR ligand reveals cancer immune heterogeneity with implications for GITR targeting. Am J Cancer Res. 2024 Apr.14(4):1634-1648. Pubmedid: 38726288. Pmcid: PMC11076267.
- Swaminathan N, Moussa P, Mody N, Lo KB, Patarroyo-Aponte G. COVID-19 in HIV-infected patients: A case series and literature review. J Med Virol. 2021 May.93(5):2557-2563. Pubmedid: 33200823. Pmcid: PMC7753685.
- Tiu A, Jorge V, Moussa P, Djibo DA, Gupta S, Alpdogan O, Dourado C. Survival Disparities of Diffuse Large B-Cell Lymphoma in a Community-Based Inner-City Cancer Center. Clin Lymphoma Myeloma Leuk. 2021 Apr.21(4):205-215. Pubmedid: 33139233.
- Moussa P, Abrahamsen G, Fodil N, Gopalakrishnan RP, Mancini M, Dissen E, Sæther PC, Wiltshire SA, Boivin GA, Caignard G, Spurkland A, Vidal SM. Reduced MCMV Δm157 viral clearance in the absence of TSAd. Sci Rep. 2015 Mar.5:9219. Pubmedid: 25783199. Pmcid: PMC4363830.
- Fodil N, Langlais D, Moussa P, Boivin GA, Di Pietrantonio T, Radovanovic I, Dumaine A, Blanchette M, Schurr E, Gros P, Vidal SM. Specific dysregulation of IFNγ production by natural killer cells confers susceptibility to viral infection. PLoS Pathog. 2014 Dec.10(12):e1004511. Pubmedid: 25473962. Pmcid: PMC4256466.
- Moussa P, Marton J, Vidal SM, Fodil-Cornu N. Genetic dissection of NK cell responses. Front Immunol. 2013 Jan.3:425. Pubmedid: 23346087. Pmcid: PMC3548222.
-
Patient Comments
0 patients rated this provider
The Provider Rating is an average of all responses to specific care provider-related questions from our nationally-recognized Press Ganey Patient Satisfaction Survey. Responses are measured on a scale of 1 to 5 with 5 being the best score.
Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.
Learn more about our patient satisfaction surveyComments
Comments are gathered from specific care provider-related questions from our Patient Satisfaction Survey . The comments are submitted by patients and reflect their views and opinions. Patients are de-identified for confidentiality and patient privacy.
Learn more about our patient comments
We post both positive and negative comments from the surveys. We do not post comments that are libelous, slanderous, profane, irrelevant or otherwise inappropriate or may risk the privacy of our patients. A “[…]” in the comments below indicates de-identified patient information or comments that are unrelated to the patient’s experience with the visit to the provider, such as comments related to another provider, about the survey itself, or otherwise completely off-topic.
Provider Ratings and comments are gathered from our nationally-recognized Press Ganey Patient Satisfaction Survey. If a provider does not have ratings or comments listed it can be for several reasons, including:
Learn more about our patient satisfaction survey, ratings and comments